Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT06831526 · RECRUITING
Trial details
- NCT number
- NCT06831526
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-06
- Primary completion
- 2029-02-28
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.